Mayra Guerrero
A5054472046- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Cardiac Structural Anomalies and Repair
- Cardiac Arrhythmias and Treatments
- Aortic Disease and Treatment Approaches
- Cardiac, Anesthesia and Surgical Outcomes
- Atrial Fibrillation Management and Outcomes
- Coronary Interventions and Diagnostics
- Cardiomyopathy and Myosin Studies
- Cardiac and Coronary Surgery Techniques
- Mechanical Circulatory Support Devices
- Venous Thromboembolism Diagnosis and Management
- Vascular Procedures and Complications
- Acute Myocardial Infarction Research
- Congenital Heart Disease Studies
- Cardiovascular Issues in Pregnancy
- Pericarditis and Cardiac Tamponade
- Cerebrovascular and Carotid Artery Diseases
- Cardiac tumors and thrombi
- Pulmonary Hypertension Research and Treatments
- Cardiovascular Effects of Exercise
- Radiation Dose and Imaging
Mayo Clinic
2019-2025
Mayo Clinic in Arizona
2018-2025
Mayo Clinic Health System
2022-2024
WinnMed
2021-2024
St.-Johannes-Hospital Dortmund
2024
Allegheny General Hospital
2024
Atlantic Health System
2024
Allegheny Health Network
2024
Lankenau Heart Institute
2024
University of Pennsylvania
2024
There are limited data on coronary obstruction following transcatheter valve-in-valve (ViV) implantation inside failed aortic bioprostheses. The objectives of this study were to determine the incidence, predictors, and clinical outcomes in ViV procedures. A total 1612 procedures from Valve-in-Valve International Data (VIVID) Registry evaluated. subject centralized blinded corelab computed tomography (CT) analysis a subset patients. virtual valve ostium distance (VTC) was determined. 37...
Based on randomized trials using first-generation devices, transcatheter aortic valve replacement (TAVR) is well established in the treatment of high-risk (HR) patients with severe stenosis (AS). To date, there a paucity adjudicated, prospective data evaluating outcomes newer generation devices and lower risk patients. We report early large, multicentre registry inoperable, HR, intermediate-risk (IR) undergoing next-generation SAPIEN 3 heart (THV). Patients severe, symptomatic AS (583 high...
Transcatheter mitral valve replacement using aortic transcatheter heart valves has recently become an alternative for patients with degenerated bioprostheses, failed surgical repairs annuloplasty rings or severe annular calcification who are poor candidates. Outcomes of these procedures collected in the Society Thoracic Surgeons/American College Cardiology/Transcatheter Valve Therapy Registry. A comprehensive analysis valve-in-valve (MViV), valve-in-ring (MViR), and valve-in-mitral (ViMAC)...
Bioprosthetic mitral valves are implanted with increasing frequency but inevitably degenerate, leading to heart failure. Reoperation is associated high morbidity and mortality. Transcatheter valve-in-valve (MViV) using balloon-expandable transcatheter has emerged as an alternative for high-surgical risk patients.To assess contemporary outcomes of SAPIEN 3 (Edwards Lifesciences) MViV replacement.In this registry-based prospective cohort study MViV, patients entered in the Society Thoracic...
Patients with severe aortic stenosis and a small annulus are at risk for impaired valvular hemodynamic performance associated adverse cardiovascular clinical outcomes after transcatheter aortic-valve replacement (TAVR).
Abstract Objective Demonstrate proof‐of‐concept validation of a computed tomography (CT) computer‐aided design prediction modeling tool to identify patients at risk for left ventricular outflow tract (LVOT) obstruction in transcatheter mitral valve replacement (TMVR). Background LVOT is significant and even fatal consequence TMVR. Methods From August 2013 2017, 38 5 centers underwent TMVR with compassionate use balloon‐expandable valves severe dysfunction because degenerative surgical ring,...
Mitral valve-in-valve (ViV) and valve-in-ring (ViR) are alternatives to surgical reoperation in patients with recurrent mitral valve failure after previous repair or replacement. Our aim was perform a large-scale analysis examining midterm outcomes ViV ViR.Patients undergoing ViR were enrolled the Valve-in-Valve International Data Registry. Cases performed between March 2006 2020. Clinical endpoints reported according Valve Academic Research Consortium (MVARC) definitions. Significant...
Background: Open surgical closure and small-bore suture-based preclosure devices have limitations when used for transcatheter aortic valve replacement, percutaneous endovascular abdominal aneurysm repair, or thoracic repair. The MANTA vascular device is a novel collagen-based technology designed to close large bore arteriotomies created by with an outer diameter ranging from 12F 25F. In this study, we determined the safety effectiveness of device. Methods Results: A prospective, single arm,...
Objectives To evaluate the outcomes of early experience percutaneous alcohol septal ablation in patients with severe left ventricular outflow tract (LVOT) obstruction post transcatheter mitral valve replacement (TMVR). Background Severe LVOT hemodynamic compromise is a complication TMVR associated high mortality. Percutaneous has recently been described as therapeutic option this setting. Methods Multicenter retrospective review clinical undergoing to treat after for stenosis annular...